These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32154013)

  • 21. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment.
    Potočnik N; Perše M; Cerar A; Injac R; Finderle Ž
    PLoS One; 2017; 12(7):e0181632. PubMed ID: 28727839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical assessment of anthracycline cardiotoxicity in laboratory animals: predictiveness and pitfalls.
    Robert J
    Cell Biol Toxicol; 2007 Jan; 23(1):27-37. PubMed ID: 17041747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation.
    L'Abbate S; Chianca M; Fabiani I; Del Franco A; Giannoni A; Vergaro G; Grigoratos C; Kusmic C; Passino C; D'Alessandra Y; Burchielli S; Emdin M; Cardinale DM
    J Cardiovasc Transl Res; 2022 Oct; 15(5):1143-1162. PubMed ID: 35312959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simian retroviruses: infection and disease--implications for immunotoxicology research in primates.
    Lerche NW
    J Immunotoxicol; 2010; 7(2):93-101. PubMed ID: 20433415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Criteria for development of animal models of diseases of the respiratory system: the comparative approach in respiratory disease model development.
    Slauson DO; Hahn FF
    Am J Pathol; 1980 Dec; 101(3 Suppl):S103-22. PubMed ID: 7457567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of drug-induced cardiovascular pathology in the beagle dog: relevance for humans.
    Greaves P
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):283-93. PubMed ID: 9784000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular safety assessments in the conscious telemetered dog: utilisation of super-intervals to enhance statistical power.
    Sivarajah A; Collins S; Sutton MR; Regan N; West H; Holbrook M; Edmunds N
    J Pharmacol Toxicol Methods; 2010; 62(1):12-9. PubMed ID: 20570743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogene activation in spontaneous and chemically induced rodent tumors: implications for risk analysis.
    Reynolds SH; Stowers SJ; Patterson RM; Maronpot RR; Anderson MW
    Environ Health Perspect; 1988 Jun; 78():175-7. PubMed ID: 3203636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic biomarkers for cardiotoxicity in rats as a sensitive tool in preclinical studies.
    Nishimura Y; Morikawa Y; Kondo C; Tonomura Y; Fukushima R; Torii M; Uehara T
    J Appl Toxicol; 2013 Oct; 33(10):1120-30. PubMed ID: 23558518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety assessment of new anticancer compound, mitoxantrone, in beagle dogs: comparison with doxorubicin. II. Histologic and ultrastructural pathology.
    Sparano BM; Gordon G; Hall C; Iatropoulos MJ; Noble JF
    Cancer Treat Rep; 1982 May; 66(5):1145-58. PubMed ID: 7083217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiotoxicity as undesired side effect in the treatment of breast cancer].
    Gramatyka M
    Postepy Hig Med Dosw (Online); 2014 May; 68():483-97. PubMed ID: 24864100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathology and pathophysiology of drug-induced arterial injury in laboratory animals and its implications on the evaluation of novel chemical entities for human clinical trials.
    Louden C; Morgan DG
    Pharmacol Toxicol; 2001 Oct; 89(4):158-70. PubMed ID: 11881965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Torsades de pointes associated with fluoroquinolones.
    Owens RC; Ambrose PG
    Pharmacotherapy; 2002 May; 22(5):663-8; discussion 668-72. PubMed ID: 12013370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of the Metabolism of Anticancer Drugs in Their Induced-Cardiotoxicity.
    Reis-Mendes AF; Sousa E; de Lourdes Bastos M; Costa VM
    Curr Drug Metab; 2015; 17(1):75-90. PubMed ID: 26526839
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.